Neovaginal Surgery Market Share, Size, Trends, Industry Analysis Report, By Product; By Treatment Type (Vaginal Agenesis Treatment, Vaginal Atresia Treatment [McIndoe, and Vecchietti Technique], Sex Reassignment Surgery); By Regions; Segment Forecast, 202

Neovaginal Surgery Market Share, Size, Trends, Industry Analysis Report, By Product; By Treatment Type (Vaginal Agenesis Treatment, Vaginal Atresia Treatment [McIndoe, and Vecchietti Technique], Sex Reassignment Surgery); By Regions; Segment Forecast, 2021 - 2028

The global neovaginal surgery market size is expected to reach USD 1.41 billion by 2028 according to a new study by Polaris Market research. The report “Neovaginal Surgery Market Share, Size, Trends, Industry Analysis Report, By Product; By Treatment Type (Vaginal Agenesis Treatment, Vaginal Atresia Treatment [McIndoe, and Vecchietti Technique], and Sex Reassignment Surgery); By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

In 2020, the sex reassignment surgeries market segment accounted for the majority of the share, and likely to register a moderate growth rate over the study period. Such a high share is mainly attributed to sex-change surgeries and social acceptance of same-sex marriages in the world.

Several market factors such as positive reimbursement scenarios and increasing demand are the pivotal factors contributing to the market segment’s growth. However, Medicare does not include sex change and other cosmetic surgeries, but few insurance firms in the developed countries are including sex reassignment surgeries in their healthcare coverage plans.

For instance, the Health Insurance Fund (HIF) of Australia, a non-profit organization includes coverage for sex-change surgeries, including neo-vaginal reconstruction. Vaginal agenesis is a rare birth defect with an incidence of 1 in 5,000 women. Several surgical methods, such as Davydov and sigmoid vaginoplasty are usually adopted for new vagina reconstruction in women suffering from agenesis. Sigmoid vaginoplasty is most efficient in low resource settings.